Revenue

Kyntra Bio's Q2 profit was driven by a one-time accounting gain, masking operating losses. Now, the firm bets its future on two critical Q4 data readouts.

Soluna Holdings reports a 145% revenue surge but a widening net loss, revealing a bold strategy to trade short-term profits for a vast green AI infrastructure.

With a $115M financing and an expanded pipeline, Assembly Biosciences is betting on novel therapies for liver and viral diseases. But can it navigate a crowded field?

The InsurTech firm posted a Q2 loss and falling revenue, but its forward-looking metrics tell a different story. A deep dive into a high-stakes bet on AI.

As Toronto prepares a final salute to the Snowbirds, their grounding reveals a strategic military shift and a major air show's plan for reinvention.

With mounting losses and a CEO's unyielding optimism, activist investors issue an ultimatum: take proteomics firm Seer private or face the consequences.

Amid rising costs, Trust Stamp pivots to the $48B Sovereign-AI market and a key EU semiconductor project, signaling a strategic shift to national tech security.

While many companies chase rapid expansion, Go Mini's is quietly building an empire by empowering its best franchisees. This is a look at their 'quality over speed' playbook.

A semiconductor firm is merging with a critical minerals miner. This isn't just M&A; it's a radical bet on vertical integration. We dig into the strategy.

With strong Q2 results as a tailwind, Interlink is making a bold move with a transformative acquisition and new sensor tech. But can it execute?

Saga Communications reports falling revenues and operating losses, yet its digital arm surges. A deep dive into the broadcaster's high-stakes balancing act.

With a new CRO and a 'historic' growth year, Auvik is betting on Daniel Ochoa's channel expertise to scale its AI platform in a crowded market.

Orbit International's Q2 report shows deepening losses from contract delays, but a rising backlog and stronger margins in key divisions suggest a complex path to recovery.

While many retailers retreat, INDOCHINO is doubling down on physical stores. A deep dive into the financial and strategic bet on a new kind of showroom.

Valvoline's $500M bond offering isn't just about debt. It's a savvy maneuver to fund future growth, reduce risk, and fortify its market position.

ZincFive's SPAC merger isn't just a deal; it's a bet on the critical battery chemistry needed to sustain the world's insatiable AI power demands.

A landmark study proves the link between environmental action and financial performance is not direct, but flows through a powerful new channel: consumer sales.

NeuPath Health's Q2 results show headline declines, but a deeper look reveals strong organic growth from record patient visits and strategic expansion.

Revenue is down, but Bragg Gaming's margins are up. A new chairman, a major acquisition, and deep cuts signal a high-stakes bet on a leaner future.

Q2 data reveals a stark divergence: private markets show steady, earnings-driven growth while public markets chase AI hype. But beneath the surface, a new era of selectivity emerges.